Source: Eur Respir J 2002; 20: 92-99
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Zetterquist W., Marteus H., Johannesson M., Nordvall S.L., Ihre E., Lundberg J.O.N., Alving K.. Exhaled carbon monoxide is not elevated in patients with asthma or cystic fibrosis. Eur Respir J 2002; 20: 92-99

Member's Comments

No comment yet.

Related content which might interest you: Nitric oxide but not carbon monoxide is continuously released in the human nasal airways Source: Eur Respir J 2002; 20: 100-103 Year: 2002 The importance of measuriing exhaled carbon monoxide in asthma and COPD Source: Eur Respir J 2003; 22: Suppl. 45, 82s Year: 2003 Exhaled nitric oxide and lower airway involvement in persistent rhinitis Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers vs induced sputum Year: 2006 Exhaled carbon monoxide (CO) as an index of monitoring inflammation in asthmatic patients Source: Eur Respir J 2002; 20: Suppl. 38, 423s Year: 2002 Prevalence of asthma and exhaled nitric oxide are increased in bleachery workers exposed to ozone Source: Eur Respir J 2004; 23: 87-92 Year: 2004 Relationship between exhaled air temperature and exhaled nitric oxide in childhood asthma Source: Eur Respir J 2002; 20: 108-111 Year: 2002 Effects of exacerbations and seasonality on exhaled nitric oxide in COPD Source: Eur Respir J 2005; 26: 1009-1015 Year: 2005 The effect of inhaled corticosteroid therapy on exhaled nitric oxide and exhaled hydrogen peroxide in asthma patients Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers vs induced sputum Year: 2006 The effect of montelukast on exhaled nitric oxide and nonvolatile markers of inflammation in the breath condensate of adults with mild asthma Source: Eur Respir J 2002; 20: Suppl. 38, 113s Year: 2002 Exhaled carbon monoxide levels during treatment of acute asthma Source: Eur Respir J 2001; 17: 1336 Year: 2001 Differences in exhaled nitric oxide levels between patients with cystic fibrosis and atopic bronchial asthma Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children Year: 2013 Domiciliary exhaled nitric oxide and eosinophilic airway inflammation in adults with asthma Source: Eur Respir J 2016; 48: 242-244 Year: 2016 Increased levels of exhaled carbon monoxide and their correlation with airflow obstruction in asthma and COPD Source: Annual Congress 2012 - Tobacco dependence and respiratory disease Year: 2012 Exhaled carbon monoxide in childhood asthma Source: Eur Respir J 2002; 20: Suppl. 38, 142s Year: 2002 Exhaled carbon monoxide is decreased in interstitial lung diseases (ILD) Source: Eur Respir J 2001; 18: Suppl. 33, 195s Year: 2001 The influence of asthma and COPD exacerbation on exhaled mitric oxide (FENO) Source: Eur Respir J 2004; 24: Suppl. 48, 409s Year: 2004 Effect of inhaled L-arginine on airway nitric oxide in cystic fibrosis patients Source: Annual Congress 2005 - Cystic fibrosis lung disease: pieces of the puzzle Year: 2005 Respiratory heat and moisture loss is associated with eosinophilic inflammation in asthma Source: Eur Respir J 2007; 29: 676-681 Year: 2007 Clinically relevant early functional and diagnostic markers of lung disease in children Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-50-2, page=120 Year: 2006 Exhaled nitric oxide in respiratory diseases other than asthma Source: Eur Respir Monogr 2010; 49: 45-55 Year: 2010